Drug eluting stents - a nightmare?

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Medical Ethics

Background:

• The use of drug-eluting stents (DES) is a subject of ongoing debate in cardiovascular medicine.
• Ensuring patient safety and informed decision-making is paramount in revascularization procedures.

Purpose of the Study:

• To address the controversial use of drug-eluting stents (DES).
• To emphasize critical factors for the appropriate application of DES in patient care.
• To highlight the importance of informed consent in revascularization strategies.

Main Methods:

• Review and emphasis of established guidelines for DES usage.
• Promotion of comprehensive patient consultation involving patients, interventionists, and cardiac surgeons.
• Discussion of legal and ethical considerations surrounding off-label DES use.

Main Results:

• Drug-eluting stents (DES) should strictly follow on-label indications.
• Informed consent is crucial for discussing all revascularization options, including surgery.
• Failure to obtain informed consent for off-label DES use may constitute a legal offense.

Conclusions:

• Adherence to on-label indications for DES is essential.
• Informed consent ensures patients are aware of all treatment alternatives.
• Patients must be informed about surgical options when experiencing new symptoms.